Literature DB >> 22890217

Alzheimer disease: blood-based biomarkers in AD--a silver lining on the horizon.

Christoph Laske.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22890217     DOI： 10.1038/nrneurol.2012.173

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN： 1759-4758            Impact factor:   42.937


× No keyword cloud information.
  9 in total

Review 1.  Alzheimer's disease.

Authors:  Henry W Querfurth; Frank M LaFerla
Journal:  N Engl J Med       Date:  2010-01-28       Impact factor: 91.245

2.  Inverse association of cortisol serum levels with T-tau, P-tau 181 and P-tau 231 peptide levels and T-tau/Abeta 1-42 ratios in CSF in patients with mild Alzheimer's disease dementia.

Authors:  Christoph Laske; Elke Stransky; Andreas Fritsche; Gerhard W Eschweiler; Thomas Leyhe
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2008-09-19       Impact factor: 5.270

Review 3.  Consensus report of the Working Group on: "Molecular and Biochemical Markers of Alzheimer's Disease". The Ronald and Nancy Reagan Research Institute of the Alzheimer's Association and the National Institute on Aging Working Group.

Authors: 
Journal:  Neurobiol Aging       Date:  1998 Mar-Apr       Impact factor: 4.673

4.  Plasma biomarkers associated with the apolipoprotein E genotype and Alzheimer disease.

Authors:  Holly D Soares; William Z Potter; Eve Pickering; Max Kuhn; Frederick W Immermann; David M Shera; Mats Ferm; Robert A Dean; Adam J Simon; Frank Swenson; Judith A Siuciak; June Kaplow; Madhav Thambisetty; Panayiotis Zagouras; Walter J Koroshetz; Hong I Wan; John Q Trojanowski; Leslie M Shaw
Journal:  Arch Neurol       Date:  2012-10

5.  Blood-based protein biomarkers for diagnosis of Alzheimer disease.

Authors:  James D Doecke; Simon M Laws; Noel G Faux; William Wilson; Samantha C Burnham; Chiou-Peng Lam; Alinda Mondal; Justin Bedo; Ashley I Bush; Belinda Brown; Karl De Ruyck; Kathryn A Ellis; Christopher Fowler; Veer B Gupta; Richard Head; S Lance Macaulay; Kelly Pertile; Christopher C Rowe; Alan Rembach; Mark Rodrigues; Rebecca Rumble; Cassandra Szoeke; Kevin Taddei; Tania Taddei; Brett Trounson; David Ames; Colin L Masters; Ralph N Martins
Journal:  Arch Neurol       Date:  2012-10

6.  Serum ceramides increase the risk of Alzheimer disease: the Women's Health and Aging Study II.

Authors:  Michelle M Mielke; Veera Vankata Ratnam Bandaru; Norman J Haughey; Jin Xia; Linda P Fried; Sevil Yasar; Marilyn Albert; Vijay Varma; Greg Harris; Eric B Schneider; Peter V Rabins; Karen Bandeen-Roche; Constantine G Lyketsos; Michelle C Carlson
Journal:  Neurology       Date:  2012-07-18       Impact factor: 9.910

7.  A serum protein-based algorithm for the detection of Alzheimer disease.

Authors:  Sid E O'Bryant; Guanghua Xiao; Robert Barber; Joan Reisch; Rachelle Doody; Thomas Fairchild; Perrie Adams; Steven Waring; Ramon Diaz-Arrastia
Journal:  Arch Neurol       Date:  2010-09

8.  Identification of a blood-based biomarker panel for classification of Alzheimer's disease.

Authors:  Christoph Laske; Thomas Leyhe; Elke Stransky; Nadine Hoffmann; Andreas J Fallgatter; Janko Dietzsch
Journal:  Int J Neuropsychopharmacol       Date:  2011-04-05       Impact factor: 5.176

9.  Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins.

Authors:  Sandip Ray; Markus Britschgi; Charles Herbert; Yoshiko Takeda-Uchimura; Adam Boxer; Kaj Blennow; Leah F Friedman; Douglas R Galasko; Marek Jutel; Anna Karydas; Jeffrey A Kaye; Jerzy Leszek; Bruce L Miller; Lennart Minthon; Joseph F Quinn; Gil D Rabinovici; William H Robinson; Marwan N Sabbagh; Yuen T So; D Larry Sparks; Massimo Tabaton; Jared Tinklenberg; Jerome A Yesavage; Robert Tibshirani; Tony Wyss-Coray
Journal:  Nat Med       Date:  2007-10-14       Impact factor: 53.440
  9 in total
  2 in total

Review 1.  Actin dynamics and cofilin-actin rods in alzheimer disease.

Authors:  James R Bamburg; Barbara W Bernstein
Journal:  Cytoskeleton (Hoboken)       Date:  2016-03-01

Review 2.  Role of amyloid peptides in vascular dysfunction and platelet dysregulation in Alzheimer's disease.

Authors:  Ilaria Canobbio; Aisha Alsheikh Abubaker; Caterina Visconte; Mauro Torti; Giordano Pula
Journal:  Front Cell Neurosci       Date:  2015-03-03       Impact factor: 5.505
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.